![]() 1010 Wins | Pfizer shares at risk following heart-drug failure Reuters - By Ransdell Pierson. NEW YORK (Reuters) - With the sudden failure of torcetrapib Pfizer Inc.'s most important experimental product financial analysts predict shares of the world's largest drugmaker could ... Pfizer shares could dive after drug failure Pfizer ends trials development on cholesterol drug |